Dr. Chong has over 30 years of vaccine research and development experience. He obtained his BSc (1978) and PhD (1983) from the Department of Biochemistry in the University of Alberta, Edmonton, Canada. Dr. Chong has developed two vaccines, Prohibit against H. Influenzae Type B (HIB) and the component pertussis vaccine, during his tenure as R&D Director in Sanofi, and one vaccine, cell-based H5N1 flu vaccine, during his directorship in NHRI vaccine centre in Taiwan. He has also served as consultants for numerous cGMP vaccine and biologic manufacturing facilities. Dr. Chong has authored over 200 original research articles and has over 80 patents filed and/or granted. He is the former Professor in China Medical University, Taiwan and Adjunct Professor in two Taiwan universities and one mainland China university. In 2023, he is appointed as Professor of Practice of The Hong Kong Polytechnic University.
Management Team
Dr. Pele CHONG
Strategic Development Director